to be honest:
- I don't really care about patent extensions. I hope this isn't wasting too much time/money. Patents are expensive and, not much use if you aren't actually in business.
- cautiously optimistic about the new CEO.
- hopeful about additional R&D incentive payment. Would be a nice little bonus.
- very optimistic about "delivery of the prototype ColoSTAT® test kits in line with future IVDR product registration and this is expected to be delivered to Rhythm in second half of CY’24."
I wasn't expecting to see much "material" progress this year but maybe there is cause for some cautious optimism.
GLTAH
Ann: Mar24 Quarterly Activities Report and Appendix 4C, page-2
Add RHY (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.0¢ |
Change
-0.002(2.78%) |
Mkt cap ! $17.40M | |||
| Open | High | Low | Value | Volume |
| 6.9¢ | 7.0¢ | 6.9¢ | $1.212K | 17.49K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 37250 | 6.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.1¢ | 15000 | 1 |
View Market Depth
| Last trade - 16.10pm 06/06/2024 (20 minute delay) ? |
|
|||||
|
Last
6.9¢ |
Change
-0.002 ( 1.43 %) |
||||
| Open | High | Low | Volume | ||
| 7.0¢ | 7.0¢ | 6.9¢ | 34578 | ||
| Last updated 15.27pm 06/06/2024 ? | |||||
| RHY (ASX) Chart |